Ex Vivo Resection and Autotransplantation for Conventionally Unresectable Tumors - An 11-year Single Center Experience.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
pubmed:
25
8
2020
medline:
11
11
2020
entrez:
25
8
2020
Statut:
ppublish
Résumé
Ex vivo surgery may provide a chance at R0 resection for conventionally unresectable tumors. However, long-term outcomes have not been well documented. In this study, we analyze our 11-year outcomes to define its role. We retrospectively analyzed 46 consecutive patients who underwent ex vivo surgery at our institution 2008-2019. The types of tumors were: carcinoma (n = 20), sarcoma (n = 20) and benign to low grade tumor (n = 6). The type of ex vivo surgery was chosen based on tumor location and vascular involvement. The most commonly performed procedure was ex vivo hepatectomy (n = 18), followed by ex vivo resection and intestinal autotransplantation (n = 12), ex vivo Whipple procedure and liver autotransplantation (n = 8) and multivisceral ex vivo procedure (n = 7). Twenty-three patients (50%) are currently alive with median follow-up of 4.0-years (11 months-11.8 years). The overall survival was 70%/59%/52%, at 1-/3-/5-years, respectively. Patient survival for benign to low grade tumors, sarcoma, and carcinoma was 100%/100%/100%, 65%/60%/50%, and 65%/45%/40%, at 1-/3-/5-years, respectively. Ninety-one percent patients had R0 resection, and 57% had no recurrence to date with median follow-up of 3.1-years. Two patients (4.3%) died within 30 days due to sepsis and gastroduodenal artety (GDA) stump blowout. Two additional patients died between 30 and 90 days due to sepsis. Perioperative mortality in the last 23 consecutive cases was limited to 1 patient who died of sepsis between 30 and 90 days. For a selected group of patients with conventionally unresectable tumors, ex vivo surgery can offer effective surgical removal with a reasonably low perioperative mortality at experienced centers.
Sections du résumé
BACKGROUND AND AIMS
Ex vivo surgery may provide a chance at R0 resection for conventionally unresectable tumors. However, long-term outcomes have not been well documented. In this study, we analyze our 11-year outcomes to define its role.
STUDY DESIGN
We retrospectively analyzed 46 consecutive patients who underwent ex vivo surgery at our institution 2008-2019.
RESULTS
The types of tumors were: carcinoma (n = 20), sarcoma (n = 20) and benign to low grade tumor (n = 6). The type of ex vivo surgery was chosen based on tumor location and vascular involvement. The most commonly performed procedure was ex vivo hepatectomy (n = 18), followed by ex vivo resection and intestinal autotransplantation (n = 12), ex vivo Whipple procedure and liver autotransplantation (n = 8) and multivisceral ex vivo procedure (n = 7). Twenty-three patients (50%) are currently alive with median follow-up of 4.0-years (11 months-11.8 years). The overall survival was 70%/59%/52%, at 1-/3-/5-years, respectively. Patient survival for benign to low grade tumors, sarcoma, and carcinoma was 100%/100%/100%, 65%/60%/50%, and 65%/45%/40%, at 1-/3-/5-years, respectively. Ninety-one percent patients had R0 resection, and 57% had no recurrence to date with median follow-up of 3.1-years. Two patients (4.3%) died within 30 days due to sepsis and gastroduodenal artety (GDA) stump blowout. Two additional patients died between 30 and 90 days due to sepsis. Perioperative mortality in the last 23 consecutive cases was limited to 1 patient who died of sepsis between 30 and 90 days.
CONCLUSIONS
For a selected group of patients with conventionally unresectable tumors, ex vivo surgery can offer effective surgical removal with a reasonably low perioperative mortality at experienced centers.
Identifiants
pubmed: 32833756
doi: 10.1097/SLA.0000000000004270
pii: 00000658-202011000-00015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
766-772Références
Demir IE, Jager C, Schlitter AM, et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. Ann Surg 2018; 268:1058–1068.
Mann GN, Mann LV, Levine EA, et al. Primary leiomyosarcoma of the inferior vena cava: a 2-institution analysis of outcomes. Surgery 2012; 151:261–267.
Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2015; 22:4020–4028.
Tan MC, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg 2016; 263:593–600.
Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004; 91:586–594.
Gorin MA, Gonzalez J, Garcia-Roig M, et al. Transplantation techniques for the resection of renal cell carcinoma with tumor thrombus: a technical description and review. Urol Oncol 2013; 31:1780–1787.
Tzanis D, Bouhadiba T, Gaignard E, et al. Major vascular resections in retroperitoneal sarcoma. J Surg Oncol 2018; 117:42–47.
Gonzalez J, Gorin MA, Garcia-Roig M, et al. Inferior vena cava resection and reconstruction: technical considerations in the surgical management of renal cell carcinoma with tumor thrombus. Urol Oncol 2014; 32:34.e19–34.e26.
Oldhafer KJ, Lang H, Schlitt HJ, et al. Long-term experience after ex situ liver surgery. Surgery 2000; 127:520–527.
Hwang R, Liou P, Kato T. Ex vivo liver resection and autotransplantation: an emerging option in selected indications. J Hepatol 2018; 69:1002–1003.
Kato T, Lobritto SJ, Tzakis A, et al. Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries. Am J Transplant 2012; 12:1323–1328.
Liou P, Kato T. Ex vivo resection and autotransplantation for pancreatic neoplasms. Surg Clin North Am 2018; 98:189–200.
Matsuoka N, Weiner JI, Griesemer AD, et al. Ex vivo pancreaticoduodenectomy and liver autotransplantation for pancreatic head tumor with extensive involvement of the hepatoduodenal ligament. Liver Transpl 2015; 21:1553–1556.
Rahnemai-Azar AA, Griesemer AD, Velasco ML, et al. Ex vivo excision of retroperitoneal soft tissue tumors: a case report. Oncol Lett 2017; 14:4863–4865.
Hardy JD. High ureteral injuries. Management by autotransplantation of the kidney. JAMA 1963; 184:97–101.
Ota K, Mori S, Awane Y, et al. Ex situ repair of renal artery for renovascular hypertension. Arch Surg 1967; 94:370–373.
Woodruff MF, Nolan B, Robson JS, et al. Renal transplantation in man. Experience in 35 cases. Lancet 1969; 1:6–12.
Pichlmayr R, Bretschneider HJ, Kirchner E, et al. Ex situ operation on the liver. A new possibility in liver surgery. Langenbecks Arch Chir 1988; 373:122–126.
Pichlmayr R, Grosse H, Hauss J, et al. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg 1990; 77:21–26.
Aji T, Dong JH, Shao YM, et al. Ex vivo liver resection and autotransplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis. J Hepatol 2018; 69:1037–1046.
Boggi U, Vistoli F, Del Chiaro M, et al. Extracorporeal repair and liver autotransplantation after total avulsion of hepatic veins and retrohepatic inferior vena cava injury secondary to blunt abdominal trauma. J Trauma 2006; 60:405–406.
Hemming AW, Cattral MS. Ex vivo liver resection with replacement of the inferior vena cava and hepatic vein replacement by transposition of the portal vein. J Am Coll Surg 1999; 189:523–526.
Hemming AW, Chari RS, Cattral MS. Ex vivo liver resection. Can J Surg 2000; 43:222–224.
Lechaux D, Megevand JM, Raoul JL, et al. Ex vivo right trisegmentectomy with reconstruction of inferior vena cava and “flop” reimplantation. J Am Coll Surg 2002; 194:842–845.
Raab R, Schlitt HJ, Oldhafer KJ, et al. Ex-vivo resection techniques in tissue-preserving surgery for liver malignancies. Langenbecks Arch Surg 2000; 385:179–184.
Wen H, Dong JH, Zhang JH, et al. Ex vivo liver resection and autotransplantation for end-stage alveolar echinococcosis: a case series. Am J Transplant 2016; 16:615–624.
Yanaga K, Kishikawa K, Shimada M, et al. Extracorporeal hepatic resection for previously unresectable neoplasms. Surgery 1993; 113:637–643.
Tzakis AG, De Faria W, Angelis M, et al. Partial abdominal exenteration, ex vivo resection of a large mesenteric fibroma, and successful orthotopic intestinal autotransplantation. Surgery 2000; 128:486–489.
Tzakis AG, Tryphonopoulos P, De Faria W, et al. Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. J Am Coll Surg 2003; 197:770–776.